NeuroSense Therapeutics Ltd. — 20-F Filings
4 20-F filings on record
This page lists all 20-F filings submitted to the SEC by NeuroSense Therapeutics Ltd. (NRSNW), sorted by most recent first. Each row links to the full filing on EdgarLookup. NeuroSense Therapeutics Ltd. has filed 4 20-F documents with the SEC since 2021. To view all SEC filings by NeuroSense Therapeutics Ltd., see the full filings list.
All
20-F
3
424B3
424B4
424B5
6-K
6-K/A
8-A12B
AW
CERT
CORRESP
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-3
FWP
POS AM
POS EX
S-8
SC 13G
SC 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 20-F | ANNUAL REPORT | 0001213900-25-029464 | Apr 7, 2025 | Dec 31, 2024 |
| 20-F | ANNUAL REPORT | 0001213900-24-030439 | Apr 4, 2024 | Dec 31, 2023 |
| 20-F | ANNUAL REPORT | 0001213900-23-021883 | Mar 22, 2023 | Dec 31, 2022 |
| 20-F | ANNUAL REPORT | 0001213900-22-019888 | Apr 14, 2022 | Dec 31, 2021 |